NVIDIA Corporation (ZNVD)
NEO Exchange · Canada · prices in CAD · close of 22 Oct 2026
Key indicators
| Last close | CAD 11.20 |
|---|---|
| 52-week range | 8.84 – 12.87 |
| Return, 1 month / 3 months | −7.0% / −0.6% |
| Return, 1 year / 3 years | +16.1% / – |
| Trend | Above 200-day, below 50-day |
| RSI (14) | 38 |
| Volatility (1 year) | 37.3% |
| Worst drawdown (1 year) | -21.0% |
| Average daily value traded | 0.02M CAD |
| Dividend yield | 0.4% |
Market X-Ray price-based
Five-year price chart navy: price · brown: 200-day average
About the company
NVIDIA Corporation designs and supplies graphics processing units and related hardware and software. Its chips power gaming graphics cards, professional workstations and data centre systems used for artificial intelligence and high-performance computing. The company also offers software platforms and tools that developers use to build and run applications on its hardware. Its customers include computer and server makers, cloud service providers, researchers and gamers. NVIDIA is based in Santa Clara, California, in the United States.
NVIDIA Corporation trades under the code ZNVD on the NEO Exchange in Canada, with its price quoted in Canadian dollars (CAD). Our dividend records, which start in 2019, show payments in 2 different calendar years. The Market X-Ray on this page is price-based and compares it with other stocks on the same exchange; it does not measure how healthy the business is.
Summary
NVIDIA Corporation (ZNVD) trades on the NEO Exchange in Canada. It last closed at CAD 11.20 on 22 October 2026.
Its price-based Market X-Ray is 54 out of 100 (a fair price profile), ranking 71 of 163 stocks on this exchange. The score describes how the stock has traded: trend, momentum, risk, liquidity and dividends, each ranked against the other stocks on its own exchange. It does not measure how healthy or cheap the business is.
Over the last year the price rose 16.1% and over the last three months it fell 0.6%. Returns are price returns, dividends not included.
Fundamental measures (valuation, growth, financial health) are not shown: we do not yet hold financial statements for this market.
The five lenses in numbers each metric is ranked against the other stocks on NEO Exchange
| Lens and metric | Value | Score | Reading |
|---|---|---|---|
| Trend | 67 · Fair | Mixed trend against its averages. | |
| Above 200-day average | 3.6% | ||
| From 52-week high | -11.5% | ||
| Momentum | 59 · Fair | Typical recent returns for this exchange. | |
| 3-month return | -0.6% | ||
| 6-month return | 4.1% | ||
| 12-month return, skipping the last month | 24.8% | ||
| Stability (higher is calmer) | 63 · Fair | Typical risk for this exchange. | |
| Volatility, 1 year (lower is calmer) | 37.3% | ||
| Worst drawdown, 1 year (smaller is calmer) | -21.0% | ||
| Liquidity | 31 · Weak | Thinly traded: prices can jump and exits can be hard. | |
| Average daily value traded | 0.02M CAD | ||
| Zero-volume days | 6.7% | ||
| Income | 22 · Weak | Dividend is small or irregular. | |
| Dividend yield | 0.4% | ||
| Years with dividends | 2 |
Strengths
No lens stands out as a clear strength against its exchange.
Weak spots
- Liquidity: Thinly traded: prices can jump and exits can be hard.
- Income: Dividend is small or irregular.
Returns
| 1 week | −2.5% |
|---|---|
| 1 month | −7.0% |
| 3 months | −0.6% |
| 6 months | +4.1% |
| 1 year | +16.1% |
| 3 years | – |
| 5 years | – |
Signals
| 50-day / 200-day average | 11.76 / 10.82 |
|---|---|
| Golden / death cross (60 days) | None |
| New 52-week high | No |
| Bullish RSI divergence | No |
| Average daily range (ATR) | 0.25 |
Technical summary
Recent dividends
| Ex-dividend date | Amount per share |
|---|---|
| 10 Sep 2026 | USD 0.0132 |
| 4 Jun 2026 | USD 0.0136 |
| 11 Mar 2026 | USD 0.0006 |
| 4 Dec 2025 | USD 0.0005 |
How to read this report
Every number comes from end-of-day prices and dividends. The Market X-Ray describes how the stock has traded, ranked against the other stocks on NEO Exchange; it does not measure how healthy or cheap the business is. The fundamental X-Ray (financial health, valuation, growth) needs financial statements, which we hold today for US stocks. See the methodology page. Educational only, not financial advice.